Orchid Pharma Statistics

Total Valuation

Orchid Pharma has a market cap or net worth of INR 36.42 billion. The enterprise value is 36.37 billion.

Market Cap	36.42B
Enterprise Value	36.37B

Important Dates

The last earnings date was Friday, May 30, 2025.

Earnings Date	May 30, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	50.72M
Shares Outstanding	n/a
Shares Change (YoY)	+4.86%
Shares Change (QoQ)	-0.00%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	15.19M

Valuation Ratios

The trailing PE ratio is 36.55 and the forward PE ratio is 27.64.

PE Ratio	36.55
Forward PE	27.64
PS Ratio	3.95
PB Ratio	2.87
P/TBV Ratio	2.91
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 30.04, with an EV/FCF ratio of -27.79.

EV / Earnings	36.50
EV / Sales	3.95
EV / EBITDA	30.04
EV / EBIT	42.04
EV / FCF	-27.79

Financial Position

The company has a current ratio of 2.83, with a Debt / Equity ratio of 0.14.

Current Ratio	2.83
Quick Ratio	1.49
Debt / Equity	0.14
Debt / EBITDA	1.49
Debt / FCF	-1.33
Interest Coverage	5.68

Financial Efficiency

Return on equity (ROE) is 8.18% and return on invested capital (ROIC) is 3.76%.

Return on Equity (ROE)	8.18%
Return on Assets (ROA)	3.19%
Return on Invested Capital (ROIC)	3.76%
Return on Capital Employed (ROCE)	5.89%
Revenue Per Employee	10.58M
Profits Per Employee	1.14M
Employee Count	871
Asset Turnover	0.57
Inventory Turnover	1.84

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -24.45% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-24.45%
50-Day Moving Average	764.11
200-Day Moving Average	1,250.41
Relative Strength Index (RSI)	47.36
Average Volume (20 Days)	20,287

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Orchid Pharma had revenue of INR 9.22 billion and earned 996.57 million in profits. Earnings per share was 19.65.

Revenue	9.22B
Gross Profit	3.78B
Operating Income	826.30M
Pretax Income	994.63M
Net Income	996.57M
EBITDA	1.17B
EBIT	826.30M
Earnings Per Share (EPS)	19.65

Full Income Statement

Balance Sheet

The company has 1.80 billion in cash and 1.75 billion in debt, giving a net cash position of 51.25 million.

Cash & Cash Equivalents	1.80B
Total Debt	1.75B
Net Cash	51.25M
Net Cash Per Share	n/a
Equity (Book Value)	12.67B
Book Value Per Share	250.11
Working Capital	5.22B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 192.15 million and capital expenditures -1.50 billion, giving a free cash flow of -1.31 billion.

Operating Cash Flow	192.15M
Capital Expenditures	-1.50B
Free Cash Flow	-1.31B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 40.97%, with operating and profit margins of 8.96% and 10.81%.

Gross Margin	40.97%
Operating Margin	8.96%
Pretax Margin	10.79%
Profit Margin	10.81%
EBITDA Margin	12.71%
EBIT Margin	8.96%
FCF Margin	n/a

Dividends & Yields

Orchid Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.86%
Shareholder Yield	n/a
Earnings Yield	2.74%
FCF Yield	-3.59%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a